This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Audiology  • Hearing Loss/ Deafness  • Middle/ External Ear Disorders  • Drug Therapy  • Adverse Effects  • Alert me on articles by topic  Social Bookmarking   What's this?

Katherine R. Kavanagh, MD; Kourosh Parham, MD, PhD; Scott R. Schoem, MD

Arch Otolaryngol Head Neck Surg. 2009;135(3):238-241.

Objective  To test for ototoxicity after prolonged ototopical fluoroquinolone use in the middle ear space using a murine model.

Design  Nonrandomized controlled trial.

Subjects  Twelve CBA/J mice.

Interventions  The mice received daily intratympanic injections of ciprofloxacin-dexamethasone otic suspension for 21 days. The contralateral ear received daily intratympanic injections of sterile isotonic sodium chloride solution (saline) as a control.

Main Outcome Measures  Click-evoked auditory brainstem response (ABR) thresholds were obtained before injection and 10 days and 3 months after injection.

Results  Mean (SEM) preinjection ABR thresholds were 47.17 (2.74) dB peak equivalent sound pressure level (peSPL) in ciprofloxacin-dexamethasone–treated ears and 45.08 (1.56) dB peSPL in saline-treated ears (P = .38). Mean (SEM) postinjection ABR thresholds in ciprofloxacin-dexamethasone–treated ears were 44.25 (1.25) dB peSPL after 10 days and 43.00 (1.51) dB peSPL after 3 months. Mean (SEM) postinjection ABR thresholds in saline-treated ears were 48.00 (1.51) dB peSPL after 10 days and 45.92 (1.79) dB peSPL after 3 months. There were no significant differences in ABR thresholds for ciprofloxacin-dexamethasone–treated ears (P = .29, P = .10) or saline-treated ears (P = .07, P = .59).

Conclusion  Ciprofloxacin-dexamethasone suspension did not cause either immediate or delayed ototoxicity after 21 days of intratympanic administration in the CBA/J mouse model.

Author Affiliations: Division of Otolaryngology–Head and Neck Surgery, Department of Surgery, University of Connecticut Health Center, Farmington (Drs Kavanagh and Parham); and Department of Otolaryngology, Connecticut Children's Medical Center, Hartford (Dr Schoem).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?